155 related articles for article (PubMed ID: 19662384)
21. Effects of citalopram and escitalopram on fMRI response to affective stimuli in healthy volunteers selected by serotonin transporter genotype.
Henry ME; Lauriat TL; Lowen SB; Churchill JH; Hodgkinson CA; Goldman D; Renshaw PF
Psychiatry Res; 2013 Sep; 213(3):217-24. PubMed ID: 23845563
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic monitoring of escitalopram by dexamethasone suppression test.
Lozano-Ortiz R; Marin-Lacasa R; Pascual-Garcia A; Santacruz-Abion MJ; Sebastian-Perez F; Orea-Ramón B
Actas Esp Psiquiatr; 2012; 40(5):275-80. PubMed ID: 23076610
[TBL] [Abstract][Full Text] [Related]
23. The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype.
Kellner M; Muhtz C; Demiralay C; Husemann J; Koelsch W; Yassouridis A; Wiedemann K
J Psychiatr Res; 2009 Mar; 43(6):642-8. PubMed ID: 18930474
[TBL] [Abstract][Full Text] [Related]
24. Escitalopram: a pharmacoeconomic review of its use in depression.
Croom KF; Plosker GL
Pharmacoeconomics; 2003; 21(16):1185-209. PubMed ID: 14594439
[TBL] [Abstract][Full Text] [Related]
25. Neuroendocrine effects of citalopram infusion in anorexia nervosa.
Mondelli V; Gianotti L; Picu A; Abbate Daga G; Giordano R; Berardelli R; Pariante CM; Fassino S; Ghigo E; Arvat E
Psychoneuroendocrinology; 2006 Nov; 31(10):1139-48. PubMed ID: 17045409
[TBL] [Abstract][Full Text] [Related]
26. The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls.
Kilkens TO; Honig A; Fekkes D; Brummer RJ
Aliment Pharmacol Ther; 2005 Nov; 22(9):865-74. PubMed ID: 16225497
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of serotoninergic challenge with oral citalopram.
Mattos P; Franco VA; Noel F; Segenreich D; Gonçalves JC
Braz J Psychiatry; 2006 Sep; 28(3):203-5. PubMed ID: 17063220
[TBL] [Abstract][Full Text] [Related]
28. A comparison of d, l-fenfluramine and citalopram challenges in healthy adults.
Flory JD; Manuck SB; Perel JM; Muldoon MF
Psychopharmacology (Berl); 2004 Jul; 174(3):376-80. PubMed ID: 14997271
[TBL] [Abstract][Full Text] [Related]
29. There is a new antidepressant escitalopram (Lexapro) that is a cousin of citalopram (Celexa). How are these two different and does the newer drug have any advantages?
Harv Ment Health Lett; 2003 Jul; 20(1):8. PubMed ID: 12888468
[No Abstract] [Full Text] [Related]
30. Hormone responses to citalopram in abstinent alcohol dependent subjects.
Gotjen D; Szabo Z; Lee S; Wand G
Alcohol Clin Exp Res; 2002 Nov; 26(11):1625-31. PubMed ID: 12436050
[TBL] [Abstract][Full Text] [Related]
31. Escitalopram: superior to citalopram or a chiral chimera?
Svensson S; Mansfield PR
Psychother Psychosom; 2004; 73(1):10-6. PubMed ID: 14665791
[TBL] [Abstract][Full Text] [Related]
32. Escitalopram: a review of its use in the management of major depressive disorder.
Murdoch D; Keam SJ
Drugs; 2005; 65(16):2379-404. PubMed ID: 16266205
[TBL] [Abstract][Full Text] [Related]
33. Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests.
Henning J; Netter P
Int J Neuropsychopharmacol; 2002 Mar; 5(1):67-71. PubMed ID: 14609009
[TBL] [Abstract][Full Text] [Related]
34. Escitalopram causes fewer seizures in human overdose than citalopram.
Yilmaz Z; Ceschi A; Rauber-Lüthy C; Sauer O; Stedtler U; Prasa D; Seidel C; Hackl E; Hoffmann-Walbeck P; Gerber-Zupan G; Bauer K; Kupferschmidt H; Kullak-Ublick GA; Wilks M
Clin Toxicol (Phila); 2010 Mar; 48(3):207-12. PubMed ID: 20170390
[TBL] [Abstract][Full Text] [Related]
35. Escitalopram continuation treatment prevents relapse of depressive episodes.
Rapaport MH; Bose A; Zheng H
J Clin Psychiatry; 2004 Jan; 65(1):44-9. PubMed ID: 14744167
[TBL] [Abstract][Full Text] [Related]
36. Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects.
Brunswick DJ; Goodman DB; O'Reardon JP; Chopra M; Amsterdam JD
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):477-80. PubMed ID: 15093954
[TBL] [Abstract][Full Text] [Related]
37. Central serotonergic hypofunction in autism: results of the 5-hydroxy-tryptophan challenge test.
Croonenberghs J; Wauters A; Deboutte D; Verkerk R; Scharpe S; Maes M
Neuro Endocrinol Lett; 2007 Aug; 28(4):449-55. PubMed ID: 17693983
[TBL] [Abstract][Full Text] [Related]
38. The citalopram challenge test in patients with major depression and in healthy controls.
Kapitany T; Schindl M; Schindler SD; Hesselmann B; Füreder T; Barnas C; Sieghart W; Kasper S
Psychiatry Res; 1999 Nov; 88(2):75-88. PubMed ID: 10622344
[TBL] [Abstract][Full Text] [Related]
39. Altered brain concentrations of citalopram and escitalopram in P-glycoprotein deficient mice after acute and chronic treatment.
Karlsson L; Carlsson B; Hiemke C; Ahlner J; Bengtsson F; Schmitt U; Kugelberg FC
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1636-44. PubMed ID: 23428338
[TBL] [Abstract][Full Text] [Related]
40. A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers.
Oranje B; Wienberg M; Glenthoj BY
Psychiatry Res; 2011 Apr; 186(2-3):431-6. PubMed ID: 20971512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
